135 related articles for article (PubMed ID: 38354603)
21. Prediction of Premalignant and Malignant Endometrial Polyps by Clinical and Hysteroscopic Features.
Shor S; Pansky M; Maymon R; Vaknin Z; Smorgick N
J Minim Invasive Gynecol; 2019; 26(7):1311-1315. PubMed ID: 30611972
[TBL] [Abstract][Full Text] [Related]
22. Prevalence and risk factors for malignancy in hysteroscopy-resected endometrial polyps.
Wong CLH; So PL
Int J Gynaecol Obstet; 2021 Dec; 155(3):433-441. PubMed ID: 33621356
[TBL] [Abstract][Full Text] [Related]
23. [Hysteroscopic evaluation of the uterine cavity in postmenopausal women with uterine bleeding].
Wierzbowski T; Gottwald L; Bieńkiewicz A; Suzin J
Ginekol Pol; 2003 Sep; 74(9):892-6. PubMed ID: 14674141
[TBL] [Abstract][Full Text] [Related]
24. The risk of premalignant and malignant pathology in endometrial polyps.
Bakour SH; Khan KS; Gupta JK
Acta Obstet Gynecol Scand; 2000 Apr; 79(4):317-20. PubMed ID: 10746849
[TBL] [Abstract][Full Text] [Related]
25. Recurrent postmenopausal bleeding: a prospective cohort study.
Smith PP; O'Connor S; Gupta J; Clark TJ
J Minim Invasive Gynecol; 2014; 21(5):799-803. PubMed ID: 24681065
[TBL] [Abstract][Full Text] [Related]
26. Risk of endometrial polyp and surgical intervention in postmenopausal women with proliferative endometrium.
Rotenberg O; Doulaveris G; Fridman D; Renz M; Kaplan J; Xie X; Goldberg GL; Dar P
Maturitas; 2023 Dec; 178():107847. PubMed ID: 37717294
[TBL] [Abstract][Full Text] [Related]
27. How often are endometrial polyps malignant in asymptomatic postmenopausal women? A multicenter study.
Ferrazzi E; Zupi E; Leone FP; Savelli L; Omodei U; Moscarini M; Barbieri M; Cammareri G; Capobianco G; Cicinelli E; Coccia ME; Donarini G; Fiore S; Litta P; Sideri M; Solima E; Spazzini D; Testa AC; Vignali M
Am J Obstet Gynecol; 2009 Mar; 200(3):235.e1-6. PubMed ID: 19027096
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic workup for postmenopausal bleeding: a randomised controlled trial.
van Hanegem N; Breijer MC; Slockers SA; Zafarmand MH; Geomini P; Catshoek R; Pijnenborg J; van der Voet LF; Dijkhuizen F; van Hoecke G; Reesink-Peters N; Veersema S; van Hooff M; van Kesteren P; Huirne JA; Opmeer BC; Bongers MY; Mol B; Timmermans A
BJOG; 2017 Jan; 124(2):231-240. PubMed ID: 27225535
[TBL] [Abstract][Full Text] [Related]
29. Clinical parameters linked with malignancy in endometrial polyps.
Gregoriou O; Konidaris S; Vrachnis N; Bakalianou K; Salakos N; Papadias K; Kondi-Pafiti A; Creatsas G
Climacteric; 2009 Oct; 12(5):454-8. PubMed ID: 19591006
[TBL] [Abstract][Full Text] [Related]
30. Clinical factors and malignancy in endometrial polyps. Analysis of 1027 cases.
Ricciardi E; Vecchione A; Marci R; Schimberni M; Frega A; Maniglio P; Caserta D; Moscarini M
Eur J Obstet Gynecol Reprod Biol; 2014 Dec; 183():121-4. PubMed ID: 25461364
[TBL] [Abstract][Full Text] [Related]
31. HISTOPATHOLOGIC FINDINGS IN WOMEN UNDERGOING HYSTEROSCOPIC RESECTION OF ENDOMETRIAL POLYPS AND UTERINE MYOMAS.
Soljačić Vraneš H; Djaković I; Vrljičak M; Đurić Orsag N; Kuna K; Kraljević Z; Leniček T; Brlečić I
Acta Clin Croat; 2019 Dec; 58(4):627-631. PubMed ID: 32595247
[TBL] [Abstract][Full Text] [Related]
32. Tamoxifen use as a malignancy risk factor in postmenopausal women with endometrial polyps.
Yela DA; Ikejiri TA; Machado CR; Mutta D; Benetti-Pinto CL
Menopause; 2019 Aug; 26(8):863-866. PubMed ID: 30969185
[TBL] [Abstract][Full Text] [Related]
33. Transvaginal ultrasound and diagnostic hysteroscopy as a predictor of endometrial polyps: risk factors for premalignancy and malignancy.
Machtinger R; Korach J; Padoa A; Fridman E; Zolti M; Segal J; Yefet Y; Goldenberg M; Ben-Baruch G
Int J Gynecol Cancer; 2005; 15(2):325-8. PubMed ID: 15823120
[TBL] [Abstract][Full Text] [Related]
34. Premalignant and malignant lesions in endometrial polyps in patients undergoing hysteroscopic polypectomy.
Lenci MA; Nascimento VA; Grandini AB; Fahmy WM; Depes Dde B; Baracat FF; Lopes RG
Einstein (Sao Paulo); 2014; 12(1):16-21. PubMed ID: 24728240
[TBL] [Abstract][Full Text] [Related]
35. Asymptomatic thickened endometrium in postmenopausal women: malignancy risk.
Famuyide AO; Breitkopf DM; Hopkins MR; Laughlin-Tommaso SK
J Minim Invasive Gynecol; 2014; 21(5):782-6. PubMed ID: 24632398
[TBL] [Abstract][Full Text] [Related]
36. Hysteroscopic Evaluation of Endometrial Changes in Breast Cancer Women with or without Hormone Therapies: Results from a Large Multicenter Cohort Study.
Chiofalo B; Mazzon I; Di Angelo Antonio S; Amadore D; Vizza E; Laganà AS; Vocaturo G; Calagna G; Favilli A; Palmara V; Maranto M; Vitale SG; Cucinella G; Granese R; Ghezzi F; Sperduti I; Triolo O
J Minim Invasive Gynecol; 2020; 27(4):832-839. PubMed ID: 31425735
[TBL] [Abstract][Full Text] [Related]
37. [Prevalence and characteristics of endometrial polyps in patients with abnormal uterine bleeding].
Vojnosanit Pregl; 2008 May; 65(5):349-52. PubMed ID: 18630127
[TBL] [Abstract][Full Text] [Related]
38. Do endometrial lesions require removal? A retrospective study.
Jiang T; Yuan Q; Zhou Q; Zhu Y; Lv S; Cao Y; Wang Q; Li K; Zhao D
BMC Womens Health; 2019 May; 19(1):61. PubMed ID: 31060530
[TBL] [Abstract][Full Text] [Related]
39. Three-year follow-up results of polypectomy with endometrial ablation in the management of endometrial polyps associated with tamoxifen in Chinese women.
Gao W; Zhang L; Li W; Li J; Wang W; Zhao W; Feng L
Eur J Obstet Gynecol Reprod Biol; 2012 Mar; 161(1):62-5. PubMed ID: 22310944
[TBL] [Abstract][Full Text] [Related]
40. To treat or not to treat? An evidence-based practice guide for the management of endometrial polyps.
Sheng KK; Lyons SD
Climacteric; 2020 Aug; 23(4):336-342. PubMed ID: 32496825
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
